MedTrace Logo

Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations

NCT04573894 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 147

Last updated 2020-10-05

No results posted yet for this study

Summary

In blood cultures, species considered as potentially contaminating (coagulase negative staphylococci (CNS), Bacillus spp., Corynebacterium spp., Cutibacterium acnes, Micrococcus spp., viridans group streptococci, and Clostridium perfringens) can, however, be responsable for true bacteremia.

Blood levels of the prohormone procalcitonin (PCT) markedly increase in the early stages of bacterial infections. The aim of our study is to determine the role of plasma PCT as a biomarker differentiating blood culture contaminations from true bacteremia.

Conditions

  • Blood Culture Contamination
  • Bacteremia
  • Contamination

Interventions

DIAGNOSTIC_TEST

Procalcitonin dosage

Plasma PCT levels measured by automated enzyme immunoassay (Kryptor).

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-07-31
Completion
2020-09-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04573894 on ClinicalTrials.gov